| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 100.00% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 181.27 | 0.29 (+0.16%) | 118.29 - 186.98 | 797.3 thousand |
Market data as of 4:00PM 05/23/13. Quotes are delayed by at least 15 min.
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.
| Open | 178.50 |
|---|---|
| Previous Close | 180.98 |
| Day's Range | 174.99 - 182.23 |
| Avg Volume (10 Day) | 801.3K |
| Total Assets | $3.00B |
| Expense Ratio | 0.48% |
| Yield (Trailing 12 Mo.) | 0.37% |
| Fund Inception | 02/05/2001 |
| Timeframe | IBB | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 7.71% | 1.93% | 3.38% |
| 3 Month | 18.32% | 7.18% | 10.04% |
| Year-to-Date | 25.64% | 12.74% | 17.90% |
| 1 Year | 38.10% | 16.89% | 26.16% |
| 3 Year | 24.12% | 12.80% | 17.80% |
| 5 Year | 17.58% | 5.21% | 13.29% |
| 10 Year | 11.81% | 7.88% | 8.84% |
| Since Inception | 4.70% | 10.38% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 0.00% | |
| Healthcare | 100.00% |
| Utilities | 0.00% | |
|---|---|---|
| Communication Services | 0.00% | |
| Energy | 0.00% | |
| Industrials | 0.00% | |
| Technology | 0.00% |
| Valuation | IBB | Category Range |
|---|---|---|
| Price/Earnings | 26.55 | |
| Price/Book | 6.16 | |
| Price/Sales | 6.66 | |
| Price/Cash Flow | 20.06 | |
| Dividend Yield | 0.32 | |
| LT Earnings | 18.41 | |
| Historical Earnings | 18.48 | |
| Sales Growth | 13.5 | |
| Cash-Flow Growth | 11.67 | |
| Book-Value Growth | 10.99 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() ![]() | |
| Risk | Above Avg | |
| Return | Above Avg |
| Beta | 0.80 |
|---|---|
| Standard Deviation | 17.43 |
| Alpha | 14.87 |
| Sharpe Ratio | 1.33 |
| Mean | 25.93 |
| R-Squared | 58.03 |
| Pretax Return | 24.12% |
|---|---|
| Tax-adjusted Return | 24.04% |
| Tax Cost Ratio | 0.06% |
| Potential Cap Gains | 10.07% |